老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagenic Therapeutics Inc

1.68
+0.06003.70%
盘前：1.66-0.0200-1.19%08:35 EST
成交量：10.01万
成交额：16.12万
市值：325.06万
市盈率：-0.13
高：1.70
开：1.58
低：1.54
收：1.62
52周最高：14.28
52周最低：1.46
股本：193.49万
流通股本：191.49万
量比：0.50
换手率：5.23%
股息：- -
股息率：- -
每股收益(TTM):-13.0507
每股收益(LYR):-15.7868
净资产收益率：-512.79%
总资产收益率：-189.60%
市净率：-36.80
市盈率(LYR):-0.11

数据加载中...

总览公司新闻资讯公告
2021/04/23

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/21

重要事件披露

8-K - Current report
2021/04/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/08

重要事件披露

8-K - Current report
2021/04/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/11

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/07

重要事件披露

8-K - Current report
2020/09/03

重要事件披露

8-K - Current report
2020/08/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/21

重要事件披露

8-K - Current report
2020/07/09

重要事件披露

8-K - Current report
2020/06/18

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多